Legislative bill overview
HR 6117 would amend the Federal Food, Drug, and Cosmetic Act to require medical device manufacturers to disclose all patient-specific data that their devices record or transmit to the manufacturer. This applies to "covered devices"—a category the bill would establish—and mandates transparency about what information is being collected from patients using these devices.
Why is this important
Medical devices increasingly collect sensitive health data (heart rates, blood pressure, glucose levels, etc.) that manufacturers use for product improvement, research, or other purposes. Currently, patients often have little visibility into what data is being captured or how it's being used. This bill would create a disclosure requirement, potentially giving patients more control over their personal health information and awareness of privacy practices.
Potential points of contention
- Definition of "covered devices": The bill references a category that would be established elsewhere, leaving ambiguity about which devices fall under the requirement and potentially creating regulatory uncertainty
- Manufacturer burden vs. patient benefit: Critics may argue the disclosure requirements add compliance costs that could be passed to consumers, while supporters contend transparency is essential
- Data security and secondary uses: The bill focuses on disclosure but doesn't explicitly address what manufacturers can do with disclosed data, leaving gaps around data protection, sale to third parties, or use for targeted marketing
